Literature DB >> 20236259

Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection?

Roberto Romero1, Nicholas Kadar, Edi Vaisbuch, Sonia S Hassan.   

Abstract

PROBLEM: The amniotic fluid embolism (AFE) syndrome is a catastrophic complication of pregnancy frequently associated with maternal death. The causes and mechanisms of disease responsible for this syndrome remain elusive. METHOD OF STUDY: We report two cases of maternal deaths attributed to AFE: (1) one woman presented with spontaneous labor at term, developed intrapartum fever, and after delivery had sudden cardiovascular collapse and disseminated intravascular coagulation (DIC), leading to death; (2) another woman presented with preterm labor and foul-smelling amniotic fluid, underwent a Cesarean section for fetal distress, and also had postpartum cardiovascular collapse and DIC, leading to death.
RESULTS: Of major importance is that in both cases, the maternal plasma concentration of tumor necrosis factor-alpha at the time of admission to the hospital and when patients had no clinical evidence of infection was in the lethal range (a lethal range is considered to be above 0.1 ng/mL).
CONCLUSION: We propose that subclinical intraamniotic infection may be a cause of postpartum cardiovascular collapse and DIC and resemble AFE. Thus, some patients with the clinical diagnosis of AFE may have infection/systemic inflammation as a mechanism of disease. These observations have implications for the understanding of the mechanisms of disease of patients who develop cardiovascular collapse and DIC, frequently attributed to AFE. It may be possible to identify a subset of patients who have biochemical and immunological evidence of systemic inflammation at the time of admission, and before a catastrophic event occurs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20236259      PMCID: PMC3021734          DOI: 10.1111/j.1600-0897.2010.00823.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  129 in total

1.  Lipid unites disparate syndromes of sepsis.

Authors:  Haichao Wang; Christopher J Czura; Kevin J Tracey
Journal:  Nat Med       Date:  2004-02       Impact factor: 53.440

2.  A randomized study of maternal serum cytokine levels following cesarean section under general or neuraxial anesthesia.

Authors:  E Dermitzaki; C Staikou; G Petropoulos; D Rizos; I Siafaka; A Fassoulaki
Journal:  Int J Obstet Anesth       Date:  2008-11-20       Impact factor: 2.603

3.  Fatal obstetric shock for pulmonary emboli of amniotic fluid.

Authors:  P E STEINER; C C LUSHBAUGH; H A FRANK
Journal:  Am J Obstet Gynecol       Date:  1949-10       Impact factor: 8.661

4.  Pulmonary embolism of amniotic fluid; report of case with review of literature.

Authors:  S M BOUTON; J R SAUNDERS
Journal:  Am J Clin Pathol       Date:  1951-06       Impact factor: 2.493

5.  Predictive value of tumor necrosis factor alpha (TNF-alpha) in preeclampsia.

Authors:  Ibrahim Serdar Serin; Bülent Ozçelik; Mustafa Basbug; Hüseyin Kiliç; Derya Okur; Rusen Erez; Ybrahim Serdar Serin; Mustafa Bapbuo; Hüseyin Kýlýç
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2002-01-10       Impact factor: 2.435

6.  Maternal vernix caseosa peritonitis following premature rupture of fetal membranes.

Authors:  I S Schwartz; G V Bello; G Feigin; D H Sherman
Journal:  JAMA       Date:  1985-08-16       Impact factor: 56.272

7.  Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture.

Authors:  D Remick; P Manohar; G Bolgos; J Rodriguez; L Moldawer; G Wollenberg
Journal:  Shock       Date:  1995-08       Impact factor: 3.454

8.  Hemodynamic observations in a patient with intrapartum amniotic fluid embolism.

Authors:  P Duff; B Engelsgjerd; L W Zingery; R W Huff; M M Montiel
Journal:  Am J Obstet Gynecol       Date:  1983-05-01       Impact factor: 8.661

Review 9.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

Review 10.  Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis.

Authors:  Peter C Taylor; Marc Feldmann
Journal:  Nat Rev Rheumatol       Date:  2009-10       Impact factor: 20.543

View more
  12 in total

1.  Clinical chorioamnionitis at term IX: in vivo evidence of intra-amniotic inflammasome activation.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Eli Maymon; Juan Pedro Kusanovic; Bogdan Panaitescu; Derek Miller; Percy Pacora; Adi L Tarca; Kenichiro Motomura; Offer Erez; Eunjung Jung; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Perinat Med       Date:  2019-04-24       Impact factor: 1.901

Review 2.  Trophoblast-microbiome interaction: a new paradigm on immune regulation.

Authors:  Gil Mor; Ja-Young Kwon
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

3.  Twenty-four percent of patients with clinical chorioamnionitis in preterm gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation.

Authors:  Kyung Joon Oh; Sun Min Kim; Joon-Seok Hong; Eli Maymon; Offer Erez; Bogdan Panaitescu; Nardhy Gomez-Lopez; Roberto Romero; Bo Hyun Yoon
Journal:  Am J Obstet Gynecol       Date:  2017-02-28       Impact factor: 8.661

4.  Placental viral infection sensitizes to endotoxin-induced pre-term labor: a double hit hypothesis.

Authors:  Ingrid Cardenas; Gil Mor; Paulomi Aldo; Sabine M Lang; Paul Stabach; Andrew Sharp; Roberto Romero; Shali Mazaki-Tovi; MariaTeresa Gervasi; Robert E Means
Journal:  Am J Reprod Immunol       Date:  2010-08-13       Impact factor: 3.886

Review 5.  DIC in Pregnancy - Pathophysiology, Clinical Characteristics, Diagnostic Scores, and Treatments.

Authors:  Offer Erez; Maha Othman; Anat Rabinovich; Elad Leron; Francesca Gotsch; Jecko Thachil
Journal:  J Blood Med       Date:  2022-01-06

Review 6.  Management of clinical chorioamnionitis: an evidence-based approach.

Authors:  Agustin Conde-Agudelo; Roberto Romero; Eun Jung Jung; Ángel José Garcia Sánchez
Journal:  Am J Obstet Gynecol       Date:  2020-09-29       Impact factor: 8.661

7.  Proposed diagnostic criteria for the case definition of amniotic fluid embolism in research studies.

Authors:  Steven L Clark; Roberto Romero; Gary A Dildy; William M Callaghan; Richard M Smiley; Arthur W Bracey; Gary D Hankins; Mary E D'Alton; Mike Foley; Luis D Pacheco; Rakesh B Vadhera; J Patrick Herlihy; Richard L Berkowitz; Michael A Belfort
Journal:  Am J Obstet Gynecol       Date:  2016-06-29       Impact factor: 8.661

8.  Nonovert disseminated intravascular coagulation (DIC) in pregnancy: a new scoring system for the identification of patients at risk for obstetrical hemorrhage requiring blood product transfusion.

Authors:  Ali Alhousseini; Roberto Romero; Neta Benshalom-Tirosh; Dereje Gudicha; Percy Pacora; Dan Tirosh; Doron Kabiri; Lami Yeo; Jecko Thachil; Chaur-Dong Hsu; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2020-02-03

9.  Cellular immune responses in amniotic fluid of women with preterm clinical chorioamnionitis.

Authors:  Jose Galaz; Roberto Romero; Yi Xu; Derek Miller; Rebecca Slutsky; Dustyn Levenson; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  Inflamm Res       Date:  2020-01-07       Impact factor: 6.986

10.  Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Authors:  Henry Adekola; Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.